MSM success stories
Return to SC Feedback page
Who is the audience?
modelers? lay public
What is the goal?
What are the topics?
Public Audience Paper 2
Who is the Audience?
What is the goal?
What are the topics?
Simulation Modeling and Systems Science to Address Health Disparities (R01Clinical Trial Not Allowed)
Applications should be relevant to the objectives of the funding opportunity announcement and to at least one of the participating institutes’ and offices' research interests. Researchers are strongly encouraged to review the general research interests of the participating ICs.
how MSM can help experimentalists
Return to SC Feedback page
Who is the audience?
experimentalists?
What is the goal?
useful modeling platforms?
--
Task Forces
Task Force Organization
reaching the the clinical stakeholders
Return to SC Feedback page
Who is the audience?
clincians
What is the goal?
What are the topics?
1) Comment from Scott L. Diamond: - I am a member of TACTIC which is a multi-center consortium on Trauma. I am working with TACTIC to analyze patient samples and data for this effort.
Letter to MSM PI's
{Final letter sent to the IMAG_MSMPI listserv (IMAG_MSMPI@LIST.NIH.GOV) on 11/24/17}
Dear MSM U01 PI's,
You are receiving this email, because you are PI or contact MPI on a project supported by the MSM U01 initiatives. As appropriate, please forward this email to all of your primary co-investigators or non-contact MPI's to ensure that all your colleagues have received this information.
Student Nominations
Return to SC Feedback page
Nominations: (Name of Nominee, Project Affiliation (PI and University), email)
1) Sarah Rebbert, GOPC Communications Associate for Bruce Lee's U01 award, JHU, sweber18@jhu.edu
Didactic Tutorial Ideas
Return to SC Feedback page
Ideas for Didactic Tutorials (Title, Presenter, Project PI/Title):
1) 1) Agent-based modeling, Reinhard Laubenbacher, Reinhard Laubenbacher/Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens (Mike Henson, 11/29/17)